BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 29661784)

  • 1. MECHANISMS IN ENDOCRINOLOGY: A sense of time of the glucocorticoid circadian clock: from the ontogeny to the diagnosis of Cushing's syndrome.
    Moreira AC; Antonini SR; de Castro M
    Eur J Endocrinol; 2018 Jul; 179(1):R1-R18. PubMed ID: 29661784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The recovery of the hypothalamo-pituitary-adrenal axis after transsphenoidal operation in three patients with Cushing's disease. The effect of prior external pituitary irradiation.
    Lamberts SW; Klijn GM; de Jong JG; Birkenhäger JC
    Acta Endocrinol (Copenh); 1981 Dec; 98(4):580-5. PubMed ID: 6272518
    [No Abstract]   [Full Text] [Related]  

  • 3. Circadian rhythms of glucocorticoid hormone actions in target tissues: potential clinical implications.
    Kino T
    Sci Signal; 2012 Oct; 5(244):pt4. PubMed ID: 23033538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic subordination stress phase advances adrenal and anterior pituitary clock gene rhythms.
    Razzoli M; Karsten C; Yoder JM; Bartolomucci A; Engeland WC
    Am J Physiol Regul Integr Comp Physiol; 2014 Jul; 307(2):R198-205. PubMed ID: 24829500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of a circadian rhythmicity of glucocorticoid secretion in a patient with Cushing's syndrome: study before and after unilateral adrenalectomy.
    Ambrosi B; Riva E; Faglia G
    J Endocrinol Invest; 1985 Aug; 8(4):363-7. PubMed ID: 2999211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid hormones are both a major circadian signal and major stress signal: How this shared signal contributes to a dynamic relationship between the circadian and stress systems.
    Spencer RL; Chun LE; Hartsock MJ; Woodruff ER
    Front Neuroendocrinol; 2018 Apr; 49():52-71. PubMed ID: 29288075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circadian rhythms in the hypothalamo-pituitary-adrenal (HPA) axis.
    Kalsbeek A; van der Spek R; Lei J; Endert E; Buijs RM; Fliers E
    Mol Cell Endocrinol; 2012 Feb; 349(1):20-9. PubMed ID: 21782883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human studies on hypothalamo-pituitary-adrenal (HPA) axis.
    Liyanarachchi K; Ross R; Debono M
    Best Pract Res Clin Endocrinol Metab; 2017 Oct; 31(5):459-473. PubMed ID: 29223281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of glucocorticoid negative feedback in the regulation of HPA axis pulsatility.
    Gjerstad JK; Lightman SL; Spiga F
    Stress; 2018 Sep; 21(5):403-416. PubMed ID: 29764284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine regulation of circadian physiology.
    Tsang AH; Astiz M; Friedrichs M; Oster H
    J Endocrinol; 2016 Jul; 230(1):R1-R11. PubMed ID: 27106109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cushing's syndrome: from physiological principles to diagnosis and clinical care.
    Raff H; Carroll T
    J Physiol; 2015 Feb; 593(3):493-506. PubMed ID: 25480800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the hypothalamo-pituitary-adrenal axis in the control of circadian blood pressure rhythm.
    Munakata M; Imai Y; Abe K; Sasaki S; Minami N; Sekino H; Yoshinaga K
    J Hypertens Suppl; 1988 Dec; 6(4):S44-6. PubMed ID: 3241233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are we in danger from an epidemic of Cushing's syndrome? Nature knows its course.
    Weaver JU
    Clin Endocrinol (Oxf); 2001 Dec; 55(6):719-21. PubMed ID: 11895210
    [No Abstract]   [Full Text] [Related]  

  • 14. Subclinical Cushing's syndrome: current concepts and trends.
    Zografos GN; Perysinakis I; Vassilatou E
    Hormones (Athens); 2014; 13(3):323-37. PubMed ID: 25079456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of the circadian CLOCK system and the HPA axis.
    Nader N; Chrousos GP; Kino T
    Trends Endocrinol Metab; 2010 May; 21(5):277-86. PubMed ID: 20106676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnosis and differential diagnosis of endogenous Cushing's syndrome.
    Makras P; Toloumis G; Papadogias D; Kaltsas GA; Besser M
    Hormones (Athens); 2006; 5(4):231-50. PubMed ID: 17178699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fixing the broken clock in adrenal disorders: focus on glucocorticoids and chronotherapy.
    Minnetti M; Hasenmajer V; Pofi R; Venneri MA; Alexandraki KI; Isidori AM
    J Endocrinol; 2020 Aug; 246(2):R13-R31. PubMed ID: 32380472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of salivary cortisol in the diagnosis of Cushing's syndrome, adrenal incidentaloma, and adrenal insufficiency.
    Ceccato F; Barbot M; Zilio M; Ferasin S; Occhi G; Daniele A; Mazzocut S; Iacobone M; Betterle C; Mantero F; Scaroni C
    Eur J Endocrinol; 2013 Jul; 169(1):31-6. PubMed ID: 23610124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ontogeny of hypothalamic glucocorticoid receptor-mediated inhibition of the hypothalamic-pituitary-adrenal axis in mice.
    Laryea G; Arnett M; Muglia LJ
    Stress; 2015; 18(4):400-7. PubMed ID: 26068518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged hypothalamic-pituitary-adrenal axis activation after acute coronary syndrome in the GENESIS-PRAXY cohort.
    Tang AR; Rabi DM; Lavoie KL; Bacon SL; Pilote L; Kline GA
    Eur J Prev Cardiol; 2018 Jan; 25(1):65-72. PubMed ID: 28969495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.